FDA DrugClass IINotable

FDA Recall: GE Healthcare Omnipaque (iohexol) Injection, 350 mg/mL (64.7%), Rx Only, Distributed by: GE Healthca

Date: 2026-04-15
Brand: GE Healthcare Ireland Limited
Category: Drug
FDA Class: Class II

Description

Presence of particulate matter

Hazard

Presence of particulate matter

Remedy

306,810 vials

Related Recalls